Uta C. Hoppe
Experienced in Hypertrophic Cardiomyopathy (HCM)

Uta C. Hoppe

Kerpener Str. 62, 
Koeln, NW, DE 
Experienced in Hypertrophic Cardiomyopathy (HCM)
Kerpener Str. 62, 
Koeln, NW, DE 
OverviewLocationsClinical Research

Overview

Uta Hoppe practices in Koeln, Germany. Ms. Hoppe is rated as an Experienced expert by MediFind in the treatment of Hypertrophic Cardiomyopathy (HCM). Her top areas of expertise are Heart Failure, Mitral Valve Regurgitation, Myocarditis, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

Her clinical research consists of co-authoring 209 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Hypertrophic Cardiomyopathy (HCM).

Gender
Female

Locations

Kerpener Str. 62, Koeln, NW 50937, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry (SMART Registry)
Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry (SMART Registry)
Enrollment Status: Completed
Publish Date: October 25, 2023
Intervention Type: Device
A Prospective, Multicenter, Randomized, Open-label, Feasibility, Safety and Efficacy Study of Renal Denervation in Patients With Chronic Heart Failure (CHF)
A Prospective, Multicenter, Randomized, Open-label, Feasibility, Safety and Efficacy Study of Renal Denervation in Patients With Chronic Heart Failure (CHF)
Enrollment Status: Withdrawn
Publish Date: May 26, 2023
Intervention Type: Device
Study Phase: Not Applicable
View 1 Less Clinical Trial

209 Total Publications

Diagnostic Biomarkers for Risk Estimation of In-Hospital and Post-Discharge Cardiovascular Mortality in ST-Segment Elevation Myocardial Infarction (STEMI) Patients.
Diagnostic Biomarkers for Risk Estimation of In-Hospital and Post-Discharge Cardiovascular Mortality in ST-Segment Elevation Myocardial Infarction (STEMI) Patients.
Journal: Journal of clinical medicine
Published: July 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Hoppe's expertise for a condition
ConditionClose
      View All 44 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile